Article Information
History
- September 24, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Abhishek Jamwal1,2,
- Cristina E. Constantin3,
- Sebastian Henrich3,5,
- Wolfgang Bildl3,
- Bernd Fakler3,4,
- Simon J. Draper1,2,
- Uwe Schulte3,4 and
- Matthew K. Higgins1,2,*
- 1Department of Biochemistry, University of Oxford, South Parks Rd, Oxford, OX1 3QU
- 2Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, University of Oxford, South Parks Rd, Oxford, OX1 3QU
- 3Institute of Physiology, Faculty of Medicine, University of Freiburg, Hermann-Herder-Str. 7, 79104 Freiburg, Germany
- 4Signalling Research Centres BIOSS and CIBSS, Schänzlestr. 18, 79104 Freiburg, Germany
- 5Roche Pharma AG, Emil-Barell Strasse 1, 79639 Grenzach-Whylen, Germany
- ↵*Corresponding author: matthew.higgins{at}bioch.ox.ac.uk
Posted September 24, 2022.
Erythrocyte invasion-neutralising antibodies prevent Plasmodium falciparum RH5 from binding to basigin-containing membrane protein complexes
